| Trial ID: | L0949 |
| Source ID: | NCT01446276
|
| Associated Drug: |
Resveratrol
|
| Title: |
Long-term Investigation of Resveratrol on Lipid Turnover in Obese Men With Nonalcoholic Fatty Liver Disease. Effects on Liver Fat Content and Basal and Insulin Stimulated FFA and VLDL-triglyceride Metabolism
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Obesity;Nonalcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: Resveratrol;Other: Placebo
|
| Outcome Measures: |
Hepatic VLDL-TG secretion and peripheral VLDL-TG clearanceBasal and insulin stimulated free fatty acid (FFA) and glucose turnover;VLDL-TG oxidation;Body composition (fat mass, fat-free mass, percent fat, visceral fat mass);lipoprotein lipase activity and fat cell size in abdominal and femoral adipose tissue biopsy;Baseline data
|
| Sponsor/Collaborators: |
University of Aarhus
|
| Gender: |
Male
|
| Age: |
25 Years65 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
26
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
|
| Start Date: |
03/10/2011
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
Denmark
|
| URL: |
http://clinicaltrials.gov/show/NCT01446276
|
